Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

AIMS: Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequently used...

Descripción completa

Detalles Bibliográficos
Autores principales: Schueler, Stephan, Silvestry, Scott C., Cotts, William G., Slaughter, Mark S., Levy, Wayne C., Cheng, Richard K., Beckman, Jennifer A., Villinger, Jonas, Ismyrloglou, Eleni, Tsintzos, Stelios I., Mahr, Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318455/
https://www.ncbi.nlm.nih.gov/pubmed/34047072
http://dx.doi.org/10.1002/ehf2.13401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318455/
https://www.ncbi.nlm.nih.gov/pubmed/34047072
http://dx.doi.org/10.1002/ehf2.13401

Ejemplares similares